Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.

Gupta S, Albertson D, Gaston D, Heilbrun ME, Agarwal N, Boucher K, Parnell TJ, Liu T, Morgans A, Madison R, Gowen K, Miller VA, Ross JS, Ali SM, Millis SZ.

Clin Genitourin Cancer. 2018 Apr;16(2):e373-e382. doi: 10.1016/j.clgc.2017.09.001. Epub 2017 Sep 7.

PMID:
28974397
2.

Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma.

Kuzman JA, Stenehjem DD, Merriman J, Agarwal AM, Patel SB, Hahn AW, Alex A, Albertson D, Gill DM, Agarwal N.

BMC Urol. 2017 Jan 5;17(1):1. doi: 10.1186/s12894-016-0192-0.

3.

Piphillin: Improved Prediction of Metagenomic Content by Direct Inference from Human Microbiomes.

Iwai S, Weinmaier T, Schmidt BL, Albertson DG, Poloso NJ, Dabbagh K, DeSantis TZ.

PLoS One. 2016 Nov 7;11(11):e0166104. doi: 10.1371/journal.pone.0166104. eCollection 2016.

4.

Durable Response to Treatment With Combination Radiotherapy and High-dose Interleukin-2 in Metastatic Chromophobe Variant Renal Cell Carcinoma.

Merriman J, Tward J, Albertson D, Dechet C, Agarwal N.

J Immunother. 2016 Feb-Mar;39(2):101-3. doi: 10.1097/CJI.0000000000000106.

PMID:
26849079
5.

Patterns and Significance of PIM Kinases in Urothelial Carcinoma.

Albertson DJ, Schmidt RL, Bearss JJ, Tripp SR, Bearss DJ, Liu T.

Appl Immunohistochem Mol Morphol. 2015 Nov-Dec;23(10):717-23. doi: 10.1097/PAI.0000000000000138.

PMID:
26551340
6.

48-DAY MANHUNT.

Sorrentino MA, Fariello S, Bobella S, Brown AJ, Wagner T, Heckman J, DeReamus D, Albertson D, Siberski DD, Pequeno RM.

JEMS. 2015 May;40(5):42-7. No abstract available.

PMID:
26302642
7.

Molecular Confirmation of Ewing Sarcoma in an 85-Year-Old Woman.

Monument MJ, Grossmann AH, Baker CC, Randall RL, Liu T, Albertson DJ.

Int J Surg Pathol. 2015 Sep;23(6):500-4. doi: 10.1177/1066896915591584. Epub 2015 Jun 26.

PMID:
26116579
8.

Canine urothelial carcinoma: genomically aberrant and comparatively relevant.

Shapiro SG, Raghunath S, Williams C, Motsinger-Reif AA, Cullen JM, Liu T, Albertson D, Ruvolo M, Bergstrom Lucas A, Jin J, Knapp DW, Schiffman JD, Breen M.

Chromosome Res. 2015 Jun;23(2):311-31. doi: 10.1007/s10577-015-9471-y. Epub 2015 Mar 18.

9.

Survival Outcomes and Tumor IMP3 Expression in Patients with Sarcomatoid Metastatic Renal Cell Carcinoma.

Tantravahi SK, Albertson D, Agarwal AM, Ravulapati S, Poole A, Patel SB, Hawatmeh JS, Straubhar AM, Liu T, Stenehjem DD, Agarwal N.

J Oncol. 2015;2015:181926. doi: 10.1155/2015/181926. Epub 2015 Jan 20.

10.

Evidence of convergent evolution in humans and macaques supports an adaptive role for copy number variation of the β-defensin-2 gene.

Ottolini B, Hornsby MJ, Abujaber R, MacArthur JA, Badge RM, Schwarzacher T, Albertson DG, Bevins CL, Solnick JV, Hollox EJ.

Genome Biol Evol. 2014 Oct 27;6(11):3025-38. doi: 10.1093/gbe/evu236.

11.

DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly.

Scheinin I, Sie D, Bengtsson H, van de Wiel MA, Olshen AB, van Thuijl HF, van Essen HF, Eijk PP, Rustenburg F, Meijer GA, Reijneveld JC, Wesseling P, Pinkel D, Albertson DG, Ylstra B.

Genome Res. 2014 Dec;24(12):2022-32. doi: 10.1101/gr.175141.114. Epub 2014 Sep 18.

12.

A small-molecule inhibitor of PIM kinases as a potential treatment for urothelial carcinomas.

Foulks JM, Carpenter KJ, Luo B, Xu Y, Senina A, Nix R, Chan A, Clifford A, Wilkes M, Vollmer D, Brenning B, Merx S, Lai S, McCullar MV, Ho KK, Albertson DJ, Call LT, Bearss JJ, Tripp S, Liu T, Stephens BJ, Mollard A, Warner SL, Bearss DJ, Kanner SB.

Neoplasia. 2014 May;16(5):403-12. doi: 10.1016/j.neo.2014.05.004. Epub 2014 Jun 18.

13.

Use of in situ hybridization for HPV in head and neck tumors: experience from a national reference laboratory.

Witt BL, Albertson DJ, Coppin MG, Horrocks CF, Post M, Gulbahce HE.

Head Neck Pathol. 2015 Mar;9(1):60-4. doi: 10.1007/s12105-014-0549-1. Epub 2014 Jun 17.

14.

Changes in abundance of oral microbiota associated with oral cancer.

Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, Nightingale K, Kerr AR, DeLacure MD, Veeramachaneni R, Olshen AB, Albertson DG.

PLoS One. 2014 Jun 2;9(6):e98741. doi: 10.1371/journal.pone.0098741. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e106297. Muy-Teck The [removed].

15.

Investigation of HOXA9 promoter methylation as a biomarker to distinguish oral cancer patients at low risk of neck metastasis.

Uchida K, Veeramachaneni R, Huey B, Bhattacharya A, Schmidt BL, Albertson DG.

BMC Cancer. 2014 May 21;14:353. doi: 10.1186/1471-2407-14-353.

16.

Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution.

Kumar P, Mukherjee M, Johnson JP, Patel M, Huey B, Albertson DG, Simin K.

PLoS Genet. 2012;8(11):e1003027. doi: 10.1371/journal.pgen.1003027. Epub 2012 Nov 15.

17.

The connectome of a decision-making neural network.

Jarrell TA, Wang Y, Bloniarz AE, Brittin CA, Xu M, Thomson JN, Albertson DG, Hall DH, Emmons SW.

Science. 2012 Jul 27;337(6093):437-44. doi: 10.1126/science.1221762.

18.

ESR1 amplification in breast cancer: controversy resolved?

Albertson DG.

J Pathol. 2012 May;227(1):1-3. doi: 10.1002/path.3999. Epub 2012 Mar 19.

PMID:
22322671
19.

Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis.

Bhattacharya A, Roy R, Snijders AM, Hamilton G, Paquette J, Tokuyasu T, Bengtsson H, Jordan RC, Olshen AB, Pinkel D, Schmidt BL, Albertson DG.

Clin Cancer Res. 2011 Nov 15;17(22):7024-34. doi: 10.1158/1078-0432.CCR-11-1944. Epub 2011 Nov 8.

20.

A woman with a lower lip nodule: what is your diagnosis?

Sarma DP, Chen M, Stevens T, Albertson D, Rusin S, Ortman S.

Patholog Res Int. 2011 Apr 14;2011:656394. doi: 10.4061/2011/656394.

21.

Unknown: Biopsy of a persistent pruritic papule on the back of a 75-year-old man. Diagnosis: Tick-bite dermatitis.

Ortman SA, Huerter C, Reinig E, Albertson D, Sarma DP.

Dermatol Online J. 2011 Mar 15;17(3):11. No abstract available.

PMID:
21426877
22.

Chromosome Organization, Mitosis, and Meiosis.

Albertson DG, Rose AM, Villeneuve AM.

In: Riddle DL, Blumenthal T, Meyer BJ, Priess JR, editors. C. elegans II. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1997. No abstract available. Chapter 3.

23.

Pink pigtail in a skin biopsy: What is your diagnosis?

Reinig EF, Albertson D, Sarma D.

Dermatol Online J. 2011 Jan 15;17(1):12.

24.

Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility.

Quigley DA, To MD, Kim IJ, Lin KK, Albertson DG, Sjolund J, Pérez-Losada J, Balmain A.

Genome Biol. 2011;12(1):R5. doi: 10.1186/gb-2011-12-1-r5. Epub 2011 Jan 18.

25.

A metastasis or a second independent cancer? Evaluating the clonal origin of tumors using array copy number data.

Ostrovnaya I, Olshen AB, Seshan VE, Orlow I, Albertson DG, Begg CB.

Stat Med. 2010 Jul 10;29(15):1608-21. doi: 10.1002/sim.3866.

26.

Subjective effects of Salvia divinorum: LSD- or marijuana-like?

Albertson DN, Grubbs LE.

J Psychoactive Drugs. 2009 Sep;41(3):213-7.

PMID:
19999674
27.

Loss of Blm enhances basal cell carcinoma and rhabdomyosarcoma tumorigenesis in Ptch1+/- mice.

Davari P, Hebert JL, Albertson DG, Huey B, Roy R, Mancianti ML, Horvai AE, McDaniel LD, Schultz RA, Epstein EH Jr.

Carcinogenesis. 2010 Jun;31(6):968-73. doi: 10.1093/carcin/bgp309. Epub 2009 Dec 8.

28.

Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway.

Halberg RB, Waggoner J, Rasmussen K, White A, Clipson L, Prunuske AJ, Bacher JW, Sullivan R, Washington MK, Pitot HC, Petrini JH, Albertson DG, Dove WF.

Cancer Res. 2009 Jul 15;69(14):5768-75. doi: 10.1158/0008-5472.CAN-09-0446. Epub 2009 Jul 7.

29.

Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.

Kwek SS, Roy R, Zhou H, Climent J, Martinez-Climent JA, Fridlyand J, Albertson DG.

Oncogene. 2009 Apr 30;28(17):1892-903. doi: 10.1038/onc.2009.34. Epub 2009 Mar 30.

30.

Genomic profiling by array comparative genomic hybridization reveals novel DNA copy number changes in breast phyllodes tumours.

Kuijper A, Snijders AM, Berns EM, Kuenen-Boumeester V, van der Wall E, Albertson DG, van Diest PJ.

Cell Oncol. 2009;31(1):31-9.

31.

Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene.

Snijders AM, Huey B, Connelly ST, Roy R, Jordan RC, Schmidt BL, Albertson DG.

Oncogene. 2009 Feb 5;28(5):625-37. doi: 10.1038/onc.2008.421. Epub 2008 Nov 17.

32.

Comparative genomic hybridization (CGH)--detection of unbalanced genetic aberrations using conventional and micro-array techniques.

Schröck E, Weaver Z, Albertson D.

Curr Protoc Cytom. 2001 Nov;Chapter 8:Unit 8.12. doi: 10.1002/0471142956.cy0812s18.

PMID:
18770739
33.

High-efficiency microarray printer using fused-silica capillary tube printing pins.

Clark SM, Hamilton GE, Nordmeyer RA, Uber D, Cornell EW, Brown N, Segraves R, Davis R, Albertson DG, Pinkel D.

Anal Chem. 2008 Oct 1;80(19):7639-42. doi: 10.1021/ac8010395. Epub 2008 Sep 3.

PMID:
18763810
34.

Angiosarcoma of the scalp mimicking a sebaceous cyst.

Pan Z, Albertson D, Bhuller A, Wang B, Shehan JM, Sarma DP.

Dermatol Online J. 2008 Jun 15;14(6):13.

PMID:
18713594
35.

Conflicting evidence on the frequency of ESR1 amplification in breast cancer.

Albertson DG.

Nat Genet. 2008 Jul;40(7):821-2. doi: 10.1038/ng0708-821. No abstract available.

PMID:
18583976
36.

The BAC resource: tools for array CGH and FISH.

Nowak NJ, Snijders AM, Conroy JM, Albertson DG.

Curr Protoc Hum Genet. 2005 Aug;Chapter 4:Unit 4.13. doi: 10.1002/0471142905.hg0413s46.

PMID:
18428377
37.

Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability.

Snijders AM, Hermsen MA, Baughman J, Buffart TE, Huey B, Gajduskova P, Roydasgupta R, Tokuyasu T, Meijer GA, Fridlyand J, Albertson DG.

Genes Chromosomes Cancer. 2008 Jan;47(1):71-83.

PMID:
17943968
38.

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

Breast Cancer Res. 2007;9(5):R59.

39.

The potential role of swift foxes (Vulpes velox) and their fleas in plague outbreaks in prairie dogs.

Salkeld DJ, Eisen RJ, Stapp P, Wilder AP, Lowell J, Tripp DW, Albertson D, Antolin MF.

J Wildl Dis. 2007 Jul;43(3):425-31.

PMID:
17699080
40.

DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification.

Nowee ME, Snijders AM, Rockx DA, de Wit RM, Kosma VM, Hämäläinen K, Schouten JP, Verheijen RH, van Diest PJ, Albertson DG, Dorsman JC.

J Pathol. 2007 Sep;213(1):46-55.

PMID:
17668415
41.

Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.

Tomioka N, Oba S, Ohira M, Misra A, Fridlyand J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.

Oncogene. 2008 Jan 17;27(4):441-9. Epub 2007 Jul 16.

PMID:
17637744
42.

FBXW7 and DNA copy number instability.

Byrd KN, Huey B, Roydasgupta R, Fridlyand J, Snijders AM, Albertson DG.

Breast Cancer Res Treat. 2008 May;109(1):47-54. Epub 2007 Jun 23.

PMID:
17588203
43.

Genome position and gene amplification.

Gajduskova P, Snijders AM, Kwek S, Roydasgupta R, Fridlyand J, Tokuyasu T, Pinkel D, Albertson DG.

Genome Biol. 2007;8(6):R120.

44.

Detection of single clone deletions using array CGH: identification of submicroscopic deletions in the 22q11.2 deletion syndrome as a model system.

Tokuyasu TA, Cotter PD, Segraves R, Harris J, Elder ME, Gonzales M, Pinkel D, Albertson DG, Rauen KA.

Am J Med Genet A. 2007 May 1;143A(9):925-32.

PMID:
17394204
45.

Deletion of chromosome 11q predicts response to anthracycline-based chemotherapy in early breast cancer.

Climent J, Dimitrow P, Fridlyand J, Palacios J, Siebert R, Albertson DG, Gray JW, Pinkel D, Lluch A, Martinez-Climent JA.

Cancer Res. 2007 Jan 15;67(2):818-26.

46.

A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.

Okabe H, Lee SH, Phuchareon J, Albertson DG, McCormick F, Tetsu O.

PLoS One. 2006 Dec 27;1:e128.

47.

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG, Waldman FM, Gray JW.

Cancer Cell. 2006 Dec;10(6):529-41.

48.

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes.

Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo WL, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW.

Cancer Cell. 2006 Dec;10(6):515-27.

49.

Regional copy number-independent deregulation of transcription in cancer.

Stransky N, Vallot C, Reyal F, Bernard-Pierrot I, de Medina SG, Segraves R, de Rycke Y, Elvin P, Cassidy A, Spraggon C, Graham A, Southgate J, Asselain B, Allory Y, Abbou CC, Albertson DG, Thiery JP, Chopin DK, Pinkel D, Radvanyi F.

Nat Genet. 2006 Dec;38(12):1386-96. Epub 2006 Nov 12. Erratum in: Nat Genet. 2008 Mar;40(3):373.

PMID:
17099711
50.

Chromosomal instability in microsatellite-unstable and stable colon cancer.

Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, Kakar S, Fridlyand J, Snijders AM, Albertson DG, Thibodeau SN, Waldman FM.

Clin Cancer Res. 2006 Nov 1;12(21):6379-85.

Supplemental Content

Loading ...
Support Center